References
- Sharma P, Hu-Lieskovan S, Wargo JA, Ribas A. Primary, adaptive, and acquired resistance to cancer immunotherapy. Cell. 2017;168(4):707–723. doi:10.1016/j.cell.2017.01.017
- Krysko DV, Garg AD, Kaczmarek A, et al. Immunogenic cell death and DAMPs in cancer therapy, nature reviews. Cancer. 2012;12(12):860–875. doi:10.1038/nrc3380
- Galluzzi L, Buqué A, Kepp O, Zitvogel L, Kroemer G. Immunogenic cell death in cancer and infectious disease, nature reviews. Immunology. 2017;17(2):97–111. doi:10.1038/nri.2016.107
- Huang P, Qian X, Chen Y, et al. Metalloporphyrin-encapsulated biodegradable nanosystems for highly efficient magnetic resonance imaging-guided sonodynamic cancer therapy. J Am Chem Soc. 2017;139(3):1275–1284. doi:10.1021/jacs.6b11846
- Yue W, Chen L, Yu L, et al. Checkpoint blockade and nanosonosensitizer-augmented noninvasive sonodynamic therapy combination reduces tumour growth and metastases in mice. Nat Commun. 2019;10(1):2025. doi:10.1038/s41467-019-09760-3
- Chen J, Luo H, Liu Y, et al. Oxygen-self-produced nanoplatform for relieving hypoxia and breaking resistance to sonodynamic treatment of pancreatic cancer. ACS Nano. 2017;11(12):12849–12862. doi:10.1021/acsnano.7b08225
- Zhang Q, Bao C, Cai X, et al. Sonodynamic therapy-assisted immunotherapy: a novel modality for cancer treatment. Cancer Sci. 2018;109(5):1330–1345. doi:10.1111/cas.13578
- Song W, Kuang J, Li CX, et al. Enhanced immunotherapy based on photodynamic therapy for both primary and lung metastasis tumor eradication. ACS Nano. 2018;12(2):1978–1989. doi:10.1021/acsnano.7b09112
- Zhang J, Chen C, Li A, et al. Immunostimulant hydrogel for the inhibition of malignant glioma relapse post-resection. Nat Nanotechnol. 2021;16(5):538–548. doi:10.1038/s41565-020-00843-7
- Song C, Phuengkham H, Kim YS, et al. Syringeable immunotherapeutic nanogel reshapes tumor microenvironment and prevents tumor metastasis and recurrence. Nature Commun. 2019;10(1):3745. doi:10.1038/s41467-019-11730-8
- Meurette O, Mehlen P. Notch Signaling in the Tumor Microenvironment. Cancer Cell. 2018;34(4):536–548. doi:10.1016/j.ccell.2018.07.009
- Zou MZ, Liu WL, Gao F, et al. Artificial natural killer cells for specific tumor inhibition and renegade macrophage re-education. Adv mater. 2019;31(43):e1904495.
- Zhai K, Huang Z, Huang Q, et al. Pharmacological inhibition of BACE1 suppresses glioblastoma growth by stimulating macrophage phagocytosis of tumor cells. Nature Cancer. 2021;2(11):1136–1151. doi:10.1038/s43018-021-00267-9
- Lambrechts D, Wauters E, Boeckx B, et al. Phenotype molding of stromal cells in the lung tumor microenvironment. Nat Med. 2018;24(8):1277–1289. doi:10.1038/s41591-018-0096-5
- Klichinsky M, Ruella M, Shestova O, et al. Human chimeric antigen receptor macrophages for cancer immunotherapy. Nat Biotechnol. 2020;38(8):947–953. doi:10.1038/s41587-020-0462-y
- DeNardo DG, Ruffell B. Macrophages as regulators of tumour immunity and immunotherapy. Nat Rev Immunol. 2019;19(6):369–382. doi:10.1038/s41577-019-0127-6
- Rodell CB, Arlauckas SP, Cuccarese MF, et al. TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy. Nat Biomed Eng. 2018;2(8):578–588. doi:10.1038/s41551-018-0236-8
- Wang YC, Wang X, Yu J, et al. Targeting monoamine oxidase A-regulated tumor-associated macrophage polarization for cancer immunotherapy. Nat Commun. 2021;12(1):3530. doi:10.1038/s41467-021-23164-2
- Anderson NR, Minutolo NG, Gill S, Klichinsky M. Macrophage-based approaches for cancer immunotherapy. Cancer Res. 2021;81(5):1201–1208. doi:10.1158/0008-5472.CAN-20-2990
- Feng Y, Mu R, Wang Z, et al. A toll-like receptor agonist mimicking microbial signal to generate tumor-suppressive macrophages. Nature Commun. 2019;10(1):2272. doi:10.1038/s41467-019-10354-2
- Bahmani B, Gong H, Luk BT, et al. Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances antitumor immunity in solid tumors. Nat Commun. 2021;12(1):1999. doi:10.1038/s41467-021-22311-z
- Wagner J, Gößl D, Ustyanovska N, et al. Mesoporous silica nanoparticles as ph-responsive carrier for the immune-activating drug resiquimod enhance the local immune response in mice. ACS Nano. 2021;15(3):4450–4466. doi:10.1021/acsnano.0c08384
- Islam MA, Rice J, Reesor E, et al. Adjuvant-pulsed mRNA vaccine nanoparticle for immunoprophylactic and therapeutic tumor suppression in mice. Biomaterials. 2021;266:120431. doi:10.1016/j.biomaterials.2020.120431
- Ji G, Zhang Y, Si X, et al. Biopolymer immune implants’ sequential activation of innate and adaptive immunity for colorectal cancer postoperative immunotherapy. Adv Mater. 2021;33(3):e2004559.
- Liang JL, Luo GF, Chen WH, Zhang XZ. Recent advances in engineered materials for immunotherapy-involved combination cancer therapy. Adv Mater. 2021;33(31):e2007630.
- Xu J, Xu L, Wang C, et al. Near-infrared-triggered photodynamic therapy with multitasking upconversion nanoparticles in combination with checkpoint blockade for immunotherapy of colorectal cancer. ACS nano. 2017;11(5):4463–4474. doi:10.1021/acsnano.7b00715
- Wang L, Wang X, Yang F, et al. Systemic antiviral immunization by virus-mimicking nanoparticles-decorated erythrocytes. Nano Today. 2021;40:101280. doi:10.1016/j.nantod.2021.101280
- Ryu KA, Stutts L, Tom JK, Mancini RJ, Esser-Kahn AP. Stimulation of innate immune cells by light-activated TLR7/8 agonists. J Am Chem Soc. 2014;136(31):10823–10825. doi:10.1021/ja412314j
- Chen Y, Shang H, Wang C, et al. RNA-seq explores the mechanism of oxygen-boosted sonodynamic therapy based on all-in-one nanobubbles to enhance ferroptosis for the treatment of HCC. Int J Nanomed. 2022;17:105–123. doi:10.2147/IJN.S343361
- Gao J, Liu J, Meng Z, et al. Ultrasound-assisted C(3)F(8)-filled PLGA nanobubbles for enhanced FGF21 delivery and improved prophylactic treatment of diabetic cardiomyopathy. Acta Biomater. 2021;130:395–408. doi:10.1016/j.actbio.2021.06.015
- Du J, Li XY, Hu H, Xu L, Yang SP, Li FH. Preparation and imaging investigation of dual-targeted C(3)F(8)-filled PLGA nanobubbles as a novel ultrasound contrast agent for breast cancer. Sci Rep. 2018;8(1):3887. doi:10.1038/s41598-018-21502-x
- Wu B, Yuan Y, Liu J, et al. Single-cell RNA sequencing reveals the mechanism of sonodynamic therapy combined with a RAS inhibitor in the setting of hepatocellular carcinoma. J Nanobiotechnol. 2021;19(1):177. doi:10.1186/s12951-021-00923-3
- Yin T, Wang P, Zheng R, et al. Nanobubbles for enhanced ultrasound imaging of tumors. Int J Nanomedicine. 2012;7:895–904. doi:10.2147/IJN.S28830
- Zhang C, Li Y, Ma X, et al. Functional micro/nanobubbles for ultrasound medicine and visualizable guidance. Sci China Chem. 2021;64(6):899–914. doi:10.1007/s11426-020-9945-4
- Wang Y, Li X, Zhou Y, Huang P, Xu Y. Preparation of nanobubbles for ultrasound imaging and intracelluar drug delivery. Int J Pharm. 2010;384(1–2):148–153. doi:10.1016/j.ijpharm.2009.09.027
- Bu X, Alheshibri M. The effect of ultrasound on bulk and surface nanobubbles: a review of the current status. Ultrason Sonochem. 2021;76:105629. doi:10.1016/j.ultsonch.2021.105629